Overslaan en naar de inhoud gaan
dr. Muriel Lins
pneumologie
algemene pneumologie, slaapgerelateerde pathologie, klinische studies
geconventioneerd
slaapcentrum

Wetenschappelijke publicaties

Efficacy of Oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial.

Suzaba Margareth Lobo, Gaétan Plantefève, Girish Nair, Adilson Joaquim Cavalcante, Nara Franzin de Moraes, Estevao Nunes, Otis Barnum, Claudio Marcel Bedrun Stadnik, Maria Patelli Lima, Muriel Lins et al.
Published: January 02, 2024. 10.1016/j.eclinm.2023.102383

Evolving to a single inhaler extrafine LABA/LAMA/ICS - Inhalation technique and adherence at the heart of COPD patient care (TRIVOLVE).

G. Brusselle, U. Himpe, P. Fievez. M. Leys, S. Perez Bogerd, R. Peché, E. Vanderhelst, M. Lins, P. Capiau. Respiratory Medicine 218 (2023) 107368

CT-derived measurements of pulmonary blood volume in small vessels and the need for supplemental oxygen in COVID-19 patients

Wendel Dierckx, Wilfried De Backer, Muriel Lins, Yinka De Meyer, Kris Ides, Jan Vandevenne, Jan De Backer, Erik Franck, Ben R. Lavon, Maarten Lanclus et al. J Appl Physiol 133:1295-1299, 2022

Trends in primary outcome parameters for respiratory trials.

Robert R. Lins, Muriel Lins, Heiko Pillu. ERS International Congress 2020 abstracts. 10.1183/13993003.congress-2020.3242

Assessment of small pulmonary blood vessels in COVID-19 patients using HRCT

Muriel Lins, Jan Vandevenne, Muhunthan Thillai, Ben R. Lavon, Maarten Lanclus, Stijn Bonte, Rik Godon, Irvin Kendall, Jan De Backker, Wifried De Backer

Sputum induction for assessment of biomarkers in early drug development

R. Lins, H. Pillu, A. Van Riel, M. Lins, F. Vanhoutte; International Journal of clinical pharmacology and therapuetics, Volume 57 (2019) - January (20-23)

P-PiXel: A 'real-life' evaluation of omalizumab use in asthmatic patients.

Alain Michils, Antoine Poskin, Jan Van Schoor, Stefaan Vancayzeele, Sandra Gurdain, Muriel Lins. September 2016 European Respiratory Journal 48(suppl 60):PA4122

P-Pixel: a 2 year ‘real-life’ evaluation of Omalizumab (Xolair) use in severe asthmatic patients.

Michils A., Poskin A., Van Schoor J, Vancayzeele S., Gurdain S, Lins M. Poster presented at ERS 2016

Postextubation obstructive pseudomembranes. A case series and review of a rare complication after endotracheal intubation

Lins Muriel, MD, Dobbeleir I, MD, Paul Germonpré, MD, Ph D, Wim Waelput, MD, Ph D, Patrick Pauwels, MD, Ph D,  Philippe G Jorens, MD, Ph D. Lung (2010) 189:81-86

Stridor due to a pseudomebrane in a 10-week-old male infant.

J.J. S. Van Dinther MD, A. Boudewijns MD PhD, J. Claes MD PhD, Ph Jorens MD PhD, M. Lins MD, Abstract ESPO, juni 2008, Budapest

Use of spirometry software in two major Belgian hospitals.

B. Dieriks, M. Behaegel, M. Lins, Poster ERS Annual congress, Munchen 2006

CPAP compliance and quality of life (QOL) according to educational level in obstructive sleep apnoe (OSA).

Johan A. Verbraecken PhD, Muriel Lins MD, Abstract ERS Annual Congress 2005

Quality of life (QOL) and CPAP compliance in workers and employees with obstructive sleep apnoe (OSA) syndrome.

Johan A. Verbraecken PhD, Muriel Lins MD, Abstract ERS Annual Congress 2005

Quality of life and CPAP compliance in obstructive sleep apnea patiënts according tot their professional activity.

Abstract BASS meeting, Sleep and profession, 25/10/2003

Evaluatie van de kwaliteit van leven bij patiënten met het obstructief slaapapnoesyndroom voor en na CPAP-behandeling.

Eindwerk ter verkrijgen van het diploma van arts. Academiejaar 2002-2003

Aanpak van moeilijk te behandelen hypertensie

Tijdschrift voor Geneeskunde, 2002, 58, nr. 22, 1494-1498

Resistente hypertensie

M. Lins, R. Lins, MS 2002, 148, 13-16

Resistente hypertensie

R. Lins, M. Lins, BHL 2001, Vol 7-Nr 7, 209-211